<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H46482C5E1E4A4C9CBAFA6F8481D2146A" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>117 HR 7830 IH: Babies Need More Formula Now Act of 2022</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2022-05-18</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">117th CONGRESS</congress><session display="yes">2d Session</session><legis-num display="yes">H. R. 7830</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20220518">May 18, 2022</action-date><action-desc><sponsor name-id="S001196">Ms. Stefanik</sponsor> (for herself, <cosponsor name-id="M001159">Mrs. Rodgers of Washington</cosponsor>, <cosponsor name-id="H001091">Mrs. Hinson</cosponsor>, and <cosponsor name-id="B000740">Mrs. Bice of Oklahoma</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Federal Food, Drug, and Cosmetic Act with respect to improving the infant formula supply chain, and for other purposes.</official-title></form><legis-body id="H0E2C900976884ECB903AF2E45CE70961" style="OLC"><section id="HF2381116B6E24C0E96A7592C25C80D6B" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Babies Need More Formula Now Act of 2022</short-title></quote>.</text></section><section id="H1A498244782445E1B1C0569318CDA20D"><enum>2.</enum><header>Definition</header><text display-inline="no-display-inline">In this Act, the term <term>infant formula</term> has the meaning given to such term in section 201 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/321">21 U.S.C. 321</external-xref>).</text></section><section id="H50771869ABD5483DA8A69F6E65128DAD" commented="no"><enum>3.</enum><header>Importation of infant formula</header><subsection id="H17EA7C1088804B44AED82C984B7E8237" commented="no"><enum>(a)</enum><header>Waiver of labeling requirements for imports</header><text display-inline="yes-display-inline">Section 412 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/350a">21 U.S.C. 350a</external-xref>) is amended by adding at the end the following:</text><quoted-block style="OLC" id="H7C691E913D92450A9CF04787A1841E3B" display-inline="no-display-inline"><subsection id="H753537ED2A9B42E883C6BD51B892AB6F" commented="no"><enum>(j)</enum><header>Waiver of labeling requirements for imports</header><paragraph id="H58B2F27FA8C14C9AB8A668C0E1951D29"><enum>(1)</enum><header>In general</header><text>The Secretary may waive any labeling requirement under this Act applicable to—</text><subparagraph id="HF8FDBE08BC5543A6B3E0362EB9CEAF4C" commented="no"><enum>(A)</enum><text display-inline="yes-display-inline">the importation of infant formula from any country that is determined by the Secretary to be implementing and enforcing requirements for infant formula that provide a similar assurance of safety as the regulatory requirements of this Act; or</text></subparagraph><subparagraph id="H057828A3586746659F2CA2F16C807D17" commented="no"><enum>(B)</enum><text>the distribution and sale of such imported infant formula.</text></subparagraph></paragraph><paragraph id="H1194A1FA67BD4F948B7420CC8E4D73A7"><enum>(2)</enum><header>Rule of construction</header><text>Nothing in paragraph (1) shall be construed to limit the authority of the Secretary to require a recall of, or otherwise impose restrictions and requirements under this Act with respect to, infant formula that is subject to a waiver under paragraph (1).</text></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block></subsection><subsection id="HC74E4B5FDD774B4EB6AFBD4C7117B190" commented="no"><enum>(b)</enum><header>Harmonization</header><text display-inline="yes-display-inline">The Secretary of Health and Human Services shall, when appropriate, enter into arrangements with other nations for the purpose of harmonizing the regulatory requirements of the United States for infant formula, including with respect to inspections, nutritional requirements, and common international labeling, with the corresponding regulatory requirements of such other nations.</text></subsection><subsection id="H6DA65FDD30A04C0AB58E6C71D0021479" commented="no"><enum>(c)</enum><header>Support for the Office of the United States Trade Representative</header><text>Section 803(c)(2) of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/383">21 U.S.C. 383(c)(2)</external-xref>) is amended by striking <quote>foods</quote> and inserting <quote>foods (including infant formula)</quote>.</text></subsection><subsection id="H7C9721E8E8054155825D1531260BD977" commented="no"><enum>(d)</enum><header>Study</header><text>The Secretary of Health and Human Services shall enter into an arrangement with the National Academy of Medicine (or, if the National Academy declines to enter into such arrangement, another appropriate entity) under which the National Academy (or other appropriate entity) agrees to—</text><paragraph id="H470221A76F1D47619B11C257B19482FE" commented="no"><enum>(1)</enum><text>conduct a study comparing infant formula in the United States and infant formula in the European Union, including with respect to nutritional content and applicable labeling and other regulatory requirements; and</text></paragraph><paragraph id="H35A9E4890617491A9C464E1E392223E7" commented="no"><enum>(2)</enum><text display-inline="yes-display-inline">not later than 1 year after the date of enactment of this Act, complete such study and submit a report on the results of such study to the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions of the Senate.</text></paragraph></subsection></section><section id="HE8EC78F95E074F6EB640EA836ED1E040"><enum>4.</enum><header>Transparency to support infant formula innovation</header><subsection id="H6FF01E461FA44623BD13E1D1D4B54AC7"><enum>(a)</enum><header>Annual report to Congress</header><text display-inline="yes-display-inline">Section 412 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/350a">21 U.S.C. 350a</external-xref>), as amended by section 3(a) of this Act, is further amended by adding at the end the following:</text><quoted-block style="OLC" id="H8D33A4A92B6246B499D7B3732B00C331" display-inline="no-display-inline"><subsection id="HCA8DD7DF5A2E49F78C85A0349BF2DA4A"><enum>(k)</enum><header>Annual report to Congress</header><text display-inline="yes-display-inline">Not later than March 30 of each year, the Secretary shall submit a report to the Congress containing, with respect to the preceding calendar year, the following information:</text><paragraph id="H48570DAA87ED4A7BA0E4CC9F7CE38CBD"><enum>(1)</enum><text>The number of submissions received by the Secretary under subsection (d).</text></paragraph><paragraph id="H49952F5DECAD43C383453C96B6BBDA25"><enum>(2)</enum><text>For each such submission—</text><subparagraph id="H68BD9306F23944059356D3D3F8999105"><enum>(A)</enum><text>the amount of time taken by the Secretary to respond;</text></subparagraph><subparagraph id="HA6301DB6CDA4423591CB26D1AB8A6484"><enum>(B)</enum><text display-inline="yes-display-inline">the number of times the Secretary requested additional information from the person making such submission; and</text></subparagraph><subparagraph id="HABEED9F5AE8848C79FBCF002DF66C69D"><enum>(C)</enum><text>whether such submission included any new ingredients that were not included in any infant formula already on the market.</text></subparagraph></paragraph><paragraph id="HE4A96F02EABF40FDB48C57BB508CA16C"><enum>(3)</enum><text>The number of inspections conducted by the Food and Drug Administration or any agent thereof to evaluate compliance with subsection (b)(2).</text></paragraph><paragraph id="HD29BA0A4A91E4CDCB299F23E95223638"><enum>(4)</enum><text>The time between any inspection referred to in paragraph (3) and any necessary reinspection to evaluate compliance with subsection (b)(2).</text></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block></subsection><subsection id="HABD4AEED93C14BDE85B54C2D1A5D9526"><enum>(b)</enum><header>Marketing submissions</header><text display-inline="yes-display-inline">Section 412 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/350a">21 U.S.C. 350a</external-xref>), as amended by subsection (a), is further amended by adding at the end the following:</text><quoted-block style="OLC" id="H735A3FEB98F349F5A739B2C7ABC62D08" display-inline="no-display-inline"><subsection id="H71EC31C4DFDB4D1AAC39BA77DBBD66B4"><enum>(l)</enum><header>Marketing submissions</header><paragraph id="H47EC97255EC9493AB7F330ADD6FDBF2F"><enum>(1)</enum><header>In general</header><text display-inline="yes-display-inline">Subject to paragraph (2), the Secretary shall respond to a submission under subsection (d) for infant formula not later than 90 days after receiving such notification.</text></paragraph><paragraph id="H2759B0A2A6B3492ABFBC63B1B7D8F748"><enum>(2)</enum><header>Expedited response</header><text display-inline="yes-display-inline">The Secretary shall respond to a submission under subsection (d) for infant formula not later than 75 days after receiving such notification if it—</text><subparagraph id="H618012533D6F4E51A63ADCD5CE6F9899"><enum>(A)</enum><text>is submitted by a manufacturer that is not already marketing infant formula in the United States; or</text></subparagraph><subparagraph id="HA50EDAFD053248A895B9272A923BF7EA"><enum>(B)</enum><text>is for infant formula containing one or more ingredients that are not contained in infant formula that is already being marketed in the United States.</text></subparagraph></paragraph><paragraph id="H2AA44F9EC5DB41FBAD11533516147500"><enum>(3)</enum><header>Notification to Congress</header><text display-inline="yes-display-inline">Whenever the Secretary fails to respond to a submission under subsection (d) by the deadline applicable under paragraph (1) or (2), the Secretary shall give notice of such failure to the Congress, including an explanation of the reasons for failing to meet the deadline.</text></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block></subsection><subsection id="HACF9009827344BC0A1594556368B3D7F"><enum>(c)</enum><header>Technical correction</header><text>Section 412(c)(1)(B) of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/350a">21 U.S.C. 350a(c)(1)(B)</external-xref>) is amended by striking <quote>subsection (c)(1)</quote> and inserting <quote>subsection (d)(1)</quote>.</text></subsection></section><section id="H13DF239E225E4D8BA99893BB25B14D45" commented="no"><enum>5.</enum><header>Reducing barriers to infant formula competition</header><text display-inline="no-display-inline">Not later than 180 days after the date of enactment of this Act, the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, shall issue guidance on which types of changes, if any, in the ingredients of infant formula may not require a new growth study to meet the requirements of section 412 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/350a">21 U.S.C. 350a</external-xref>).</text></section><section id="H8D6AA303818849759373856536724F65"><enum>6.</enum><header>Coordination of efforts to mitigate shortages of infant formula</header><text display-inline="no-display-inline">The Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, shall require appropriate staff of the Office of Nutrition and Food Labeling, and the Office of Compliance, of the Center for Food Safety and Applied Nutrition, to meet at least biweekly to discuss, with respect to infant formula, pending inspections, the findings of pending and concluded inspections, and any need for additional inspections.</text></section><section id="HF34AE15796294A0192B5B4CBB840E953"><enum>7.</enum><header>Importation for personal use</header><subsection id="H8D8E163868554146A93FE986F9393227"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">During the period of 90 days following the date of enactment of this Act, a person may, without prior notice to the Food and Drug Administration, import up to a three-month supply of infant formula for personal use from Canada, the European Union, or any country that is determined by the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to have safety standards for infant formula similar to such standards applicable under the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/301">21 U.S.C. 301 et seq.</external-xref>).</text></subsection><subsection id="H44F51430C2AE45FDA53AC55EE9553B9E"><enum>(b)</enum><header>Limitations</header><text>Infant formula may be imported pursuant to subsection (a) only if the infant formula—</text><paragraph id="HDE981D463E404B03859A801A74D1A7E3"><enum>(1)</enum><text>is exclusively for personal use and will not be commercialized or promoted; and</text></paragraph><paragraph id="HA812A40340A145FB92DBD00D879E1727"><enum>(2)</enum><text>does not present an unreasonable risk to human health.</text></paragraph></subsection><subsection id="H8EC4FE9AA9AE40A2ADC6CC83F74BF894"><enum>(c)</enum><header>Reporting of adverse events</header><text>If a health care provider becomes aware of any adverse event which the health care provider reasonably suspects to be associated with infant formula imported pursuant to subsection (a), the health care provider shall report such adverse event to the Food and Drug Administration. </text></subsection><subsection id="H9C561D144B654D259C2452F7F781BF4C"><enum>(d)</enum><header>Public notice</header><text>The Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, shall post on the public website of the Food and Drug Administration notice that—</text><paragraph id="H7E445E568B9746B5AE5ABA8C0B3C1788"><enum>(1)</enum><text>infant formula imported pursuant to subsection (a) may not have been manufactured in a facility that has been inspected by the Food and Drug Administration;</text></paragraph><paragraph id="H93C0192FF62447579AAFC27BD6CAA8DA"><enum>(2)</enum><text>the labeling of such infant formula may not meet the standards and other requirements applicable with respect to infant formula under the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/301">21 U.S.C. 301 et seq.</external-xref>); and</text></paragraph><paragraph id="HB4AAE70123764AF0AE99C5C4EFEBA6BA"><enum>(3)</enum><text>the nutritional content of the infant formula may vary from that of infant formula meeting such standards and other requirements.</text></paragraph></subsection><subsection id="H375D9375288A4F97A06FFB1E087F5CE7"><enum>(e)</enum><header>Sense of Congress</header><text>It is the sense of Congress that persons considering the personal importation of infant formula should consult with their pediatrician about such importation.</text></subsection></section><section id="H358CA44158CA41D2A4A68296CDAC5D35"><enum>8.</enum><header>Consideration of supply effects prior to recommending or requiring a recall</header><subsection id="HEC8089E119944FA885303746C0341D83"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">Section 412(f) of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/350a">21 U.S.C. 350a(f)(2)</external-xref>) is amended by adding at the end the following:</text><quoted-block style="OLC" id="H3A3C326F55964C958B9521A438D982F0" display-inline="no-display-inline"><paragraph id="HE8CD564A19AA4E30A2927EB04EB84126" indent="up1"><enum>(4)</enum><text display-inline="yes-display-inline">Before recommending or requiring any recall of infant formula due exclusively to labeling deficiencies, the Secretary shall ensure that the supply of infant formula in the United States will not be negatively affected by such recall.</text></paragraph><after-quoted-block>.</after-quoted-block></quoted-block></subsection><subsection id="HDDC12CF9A5BD438CBB68EFD006CC3A81"><enum>(b)</enum><header>Regulations</header><text display-inline="yes-display-inline">Not later than 3 months after the date of enactment of this Act, the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, shall issue or update such regulations as may be necessary to implement paragraph (4) of section 412(f) of the Federal Food, Drug, and Cosmetic Act, as added by subsection (a).</text></subsection></section><section id="H7D88CBE3260D43B98D88DC723E6F4622"><enum>9.</enum><header>Congressional notification</header><subsection id="HE867E5B61F0948BBAE12D2A6BFD66DC6"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">Not later than 24 hours after the initiation of a recall of infant formula, the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, shall submit to the Congress a notification of such recall.</text></subsection><subsection id="H5252BA16101E4A5396A4D318335F3811"><enum>(b)</enum><header>Contents</header><text>A notification under subsection (a) shall include the following:</text><paragraph id="H320802F820D449B794EBFAB27428382F"><enum>(1)</enum><text>If the recall is required by the Food and Drug Administration, a summary of the determination of a case of adulterated or misbranded infant formula that presents a risk to human health.</text></paragraph><paragraph id="HE74F38172BBD46148F3D6A304EE84D74"><enum>(2)</enum><text>If the recall is voluntarily initiated by the manufacturer, a summary of the information provided to the Food and Drug Administration by the manufacturer regarding infant formula that has left the control of the manufacturer that may be adulterated or misbranded.</text></paragraph><paragraph id="HC5496969DF0541CF94737D94D0BB2245"><enum>(3)</enum><text>Specification of when the Food and Drug Administration was first made aware of the instance or circumstances surrounding the recall.</text></paragraph><paragraph id="H3295F6CE57E4440AAB3AFC07F08417FD"><enum>(4)</enum><text>An initial estimate of the disruption in domestic production that may result from the recall.</text></paragraph></subsection></section><section id="H2C062C61526D4172B5EC80A9DBED750C"><enum>10.</enum><header>Report to Congress</header><subsection id="H3944A46612FA49C39A5864210E99A0BE"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">Not later than 14 days after the initiation of a recall of infant formula, the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, shall submit a report to the Congress regarding such recall.</text></subsection><subsection id="H16431101EE10472FA8BBCA64E8D58DAA"><enum>(b)</enum><header>Contents</header><text>A report under subsection (a) shall include the following:</text><paragraph id="H0C2BB4AE1ECB43DB8346E59482254E92"><enum>(1)</enum><text>A plan (including an estimated timeline) of actions the Food and Drug Administration and the manufacturer will take—</text><subparagraph id="HB8FBFA7CD8074C07AD43E6A93F9E9B48"><enum>(A)</enum><text>to identify and address any cause of adulteration or misbranding; and</text></subparagraph><subparagraph id="H2E8C05086FF74674BF2C98377F63A100"><enum>(B)</enum><text display-inline="yes-display-inline">to restore operation of the impacted facilities to meet production levels in place prior to the recall.</text></subparagraph></paragraph><paragraph id="HCA65F1BB43CB4F3BAA2B977743C886C0"><enum>(2)</enum><text>The current domestic supply of infant formula, including—</text><subparagraph id="HA507B8AF9E1A4A38BBE0A960C7C440EE"><enum>(A)</enum><text>a breakdown of the specific types of formula involved; and</text></subparagraph><subparagraph id="HC3D20123C49243E19009B78D58599235"><enum>(B)</enum><text>an estimate of how long current supplies will last.</text></subparagraph></paragraph><paragraph id="H9050AC48E0D84B6E87681918812A628B"><enum>(3)</enum><text>In the case that a recall and subsequent actions to respond to the recall impact over 10 percent of the domestic production of infant formula, a plan to backfill supplies if the current domestic supply of infant formula has or is expected to fall below the level demanded during the disruption in domestic production, which plan shall include—</text><subparagraph id="H209E87BC86AF43978DCF58040DF3FE2A"><enum>(A)</enum><text>actions to work with the impacted manufacturer or other manufacturers to increase production; and</text></subparagraph><subparagraph id="HBEA4413E01364AE6A8AC26E925E695A7"><enum>(B)</enum><text>specification of—</text><clause id="HC36EB938054945EDABE348ACBA104935"><enum>(i)</enum><text>any additional authorities needed regarding production or importation to fill a supply gap; and</text></clause><clause id="HE34DC0A708744A2A8200BE659586A439"><enum>(ii)</enum><text>any supplemental funding necessary to address the shortage.</text></clause></subparagraph></paragraph></subsection></section><section id="H8E4F9ED450FB48F3AEB5A48FAB5E8A29"><enum>11.</enum><header>Coordination with manufacturer on restoring production</header><subsection id="H747DECB736194F62A4502F99C1E18FD5"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">Upon completing an inspection of an infant formula manufacturing facility impacted by a recall, the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, shall provide the manufacturer involved a list of any actions necessary—</text><paragraph id="HA77BA150A0DE408DA81AFC9ADD4C488D"><enum>(1)</enum><text>to address deficiencies contributing to the potential adulteration or misbranding of product at the facility; and</text></paragraph><paragraph id="HE232BB35A7A747B7B79F45326D22DAA9"><enum>(2)</enum><text>to safely restart production at the facility.</text></paragraph></subsection><subsection id="H3075BDAFBBCC4C79B83EB2419C58AB2F"><enum>(b)</enum><header>Response to manufacturer</header><text display-inline="yes-display-inline">Not later than 7 days after receiving a written communication from a manufacturer of infant formula regarding safely restoring production following a recall of such product, the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, shall provide a substantive response to such communication, including any necessary next steps.</text></subsection></section></legis-body></bill> 

